Zhang Lin, Yang Ziliang, Yin Yueqi, Huang Wenzan, Yi Tianfei, Ping Jianming, Liu Liya, Shen Peng, Sun Yexiang, Lin Hongbo
Yinzhou District Center for Disease Control and Prevention, Ningbo, Zhejiang, China.
Medical School, Department of Preventive Medicine, Ningbo University, Ningbo, Zhejiang, PR China.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2319967. doi: 10.1080/21645515.2024.2319967. Epub 2024 Mar 11.
Congenital heart disease (CHD) represents a significant population warranting particular attention concerning vaccination coverage. To comprehend the vaccination status of CHD within Yinzhou District, Ningbo City, China, and to facilitate the formulation of preventive, control, and immunization strategies against vaccine-preventable diseases in children with congenital heart conditions. Using the China Yinzhou Electronic Health Record Study (CHERRY) database, we analyzed the vaccination coverage of children with CHD born between January 1, 2016 and September 20, 2021, and analyzed the influencing factors associated with the level of vaccination coverage. This study involved 762 children diagnosed with CHD at the age of 12 months, revealing that 86.74% of these children had received at least one dose of the National Immunization Program (NIP) vaccines. The coverage for non-NIP vaccines, such as the rotavirus vaccine, influenza vaccine, Influenza Haemophilus influenzae Type b (Hib) Conjugate Vaccine, 13-valent pneumococcal conjugate vaccine (PCV13), and inactivated enterovirus type 71 vaccine (EV71), stood at 27.30%, 7.74%, 63.25%, 33.76%, and 34.51%, respectively. The completion coverage for the entire vaccination schedule were 27.30%, 5.51%, 55.77%, 34.25%, and 25.59%, respectively. There was a statistically significant correlation between vaccination coverage in classification of diagnostic medical institutions and the types of diagnosed diseases. Compared to their typically developing counterparts, 12-month-old children afflicted with CHD exhibit a slightly diminished vaccination coverage, alongside a discernible inclination toward delayed vaccination. Notably, the determination to undergo vaccinations seems predominantly influenced by the classification of diagnostic medical institutions. In practical terms, proactive measures involving early diagnosis, comprehensive health assessments, and timely interventions ought to be implemented to enhance vaccination rates while prioritizing safety.
先天性心脏病(CHD)患者是一个需要特别关注疫苗接种覆盖率的重要群体。为了解中国宁波市鄞州区先天性心脏病患者的疫苗接种状况,并为制定针对先天性心脏病患儿疫苗可预防疾病的预防、控制和免疫策略提供便利。利用中国鄞州电子健康记录研究(CHERRY)数据库,我们分析了2016年1月1日至2021年9月20日期间出生的先天性心脏病患儿的疫苗接种覆盖率,并分析了与疫苗接种覆盖率水平相关的影响因素。本研究纳入了762名12个月大时被诊断为先天性心脏病的儿童,结果显示,这些儿童中有86.74%至少接种了一剂国家免疫规划(NIP)疫苗。轮状病毒疫苗、流感疫苗、b型流感嗜血杆菌结合疫苗(Hib)、13价肺炎球菌结合疫苗(PCV13)和肠道病毒71型灭活疫苗(EV71)等非NIP疫苗的接种率分别为27.30%、7.74%、63.25%、33.76%和34.51%。整个疫苗接种程序的完成率分别为27.30%、5.51%、55.77%、34.25%和25.59%。诊断医疗机构分类中的疫苗接种覆盖率与诊断疾病类型之间存在统计学显著相关性。与发育正常的同龄人相比,患有先天性心脏病的12个月大儿童的疫苗接种覆盖率略有下降,同时明显倾向于延迟接种。值得注意的是,是否接种疫苗的决定似乎主要受诊断医疗机构分类的影响。实际上,应采取包括早期诊断、全面健康评估和及时干预在内的积极措施,在确保安全的前提下提高疫苗接种率。